|
Report Date : |
29.05.2014 |
IDENTIFICATION DETAILS
|
Name : |
C-PHARMACHEM CO
LTD |
|
|
|
|
Registered Office : |
4Fl Nam Giao Bldg 261-263 Phan Xich Long St Ward 2, Phu Nhuan, Ho Chi
Minh |
|
|
|
|
Country : |
Viet nam |
|
|
|
|
Date of Incorporation : |
August 2012 |
|
|
|
|
Legal Form : |
Private Company with Limited Liability |
|
|
|
|
Line of Business : |
Trader of
Industrial Chemicals, Veterinary Medicines & Pharmaceutical Products |
|
|
|
|
No of Employees : |
26 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow But Correct |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2014
|
Country Name |
Previous Rating (31.12.2013) |
Current Rating (31.03.2014) |
|
Viet nam
|
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderate Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderate High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
vietnam ECONOMIC OVERVIEW
Vietnam is a
densely-populated developing country that has been transitioning from the
rigidities of a centrally-planned economy since 1986. Vietnamese authorities
have reaffirmed their commitment to economic modernization in recent years.
Vietnam joined the World Trade Organization in January 2007, which has promoted
more competitive, export-driven industries. Vietnam became an official negotiating
partner in the Trans-Pacific Partnership trade agreement in 2010. Agriculture's
share of economic output has continued to shrink from about 25% in 2000 to less
than 20% in 2013, while industry's share increased from 36% to more than 42% in
the same period. State-owned enterprises account for about 40% of GDP. Poverty
has declined significantly, and Vietnam is working to create jobs to meet the
challenge of a labor force that is growing by more than one million people
every year. The global recession hurt Vietnam's export-oriented economy, with
GDP in 2013 growing at 5%, the slowest rate of growth since 1999. In 2013,
however, exports increased by more than 12%, year-on-year; several
administrative actions brought the trade deficit back into balance. Between
2008 and 2011, Vietnam's managed currency, the dong, was devalued in excess of
20%, but its value remained relatively stable in 2013. Hanoi has oscillated
between promoting growth and emphasizing macroeconomic stability in recent
years. In February 2011, the government shifted from policies aimed at
achieving a high rate of economic growth, which had stoked inflation, to those
aimed at stabilizing the economy, through tighter monetary and fiscal control.
Although Vietnam unveiled a broad, "three pillar" economic reform
program in early 2012, proposing the restructuring of public investment,
state-owned enterprises, and the banking sector, little perceptible progress
has been made. Vietnam's economy continues to face challenges from an
undercapitalized banking sector. Non-performing loans weigh heavily on banks
and businesses.
|
Source
: CIA |
|
Company Details |
||
|
Organization Name |
: |
C-PHARMACHEM CO LTD |
|
Address |
: |
4Fl Nam Giao Bldg
261-263 Phan Xich Long St Ward 2, Phu Nhuan, Ho Chi Minh |
|
Country |
: |
Vietnam |
|
Phone (S) |
: |
[+84] 8-39959954 |
|
Facsimile |
: |
[+84] 8-39959957 |
|
Email |
: |
|
|
Website |
: |
|
|
Primary Business
Activity |
: |
Trader |
|
Key Industry |
: |
Medical Equipment &
Pharmaceutical |
|
Key Facts |
||
|
Registered Legal Address |
: |
4Fl Nam Giao Bldg
261-263 Phan Xich Long St Ward 2, Phu Nhuan, Ho Chi Minh |
|
Operational Address |
: |
4Fl Nam Giao Bldg
261-263 Phan Xich Long St Ward 2, Phu Nhuan, Ho Chi Minh |
|
Issuing Authority |
: |
Dept. of Planning &
Investment - Ho Chi Minh |
|
License Number |
: |
0304251206 |
|
License Status |
: |
License exists - Normal. |
|
Legal Form - Category |
: |
Private Company with
Limited Liability |
|
Legal Form |
: |
Company Limited |
|
Legal Form -
Abbreviation |
: |
CO LTD |
|
Operational Status of
Business |
: |
Normal |
|
Date of Registration |
: |
Aug, 2012 |
|
Employees |
: |
26 |
|
Capital |
: |
US$ 239,951 |
|
Note |
: |
(1) Legal status of the English corporate name |
Key Person
|
Legal Title |
: |
Managing Director |
|
Name |
: |
Ms. Do Thi Thanh Ha |
|
Nationality |
: |
Vietnamese |
|
COMPANY MANAGEMENT |
|||||||||||||||
|
Management Listings |
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
COMPANY DIRECTORS |
||||||||||||
|
|
REPUTATION |
|
Due to the recent
incorporation of the C-PHARMACHEM CO LTD, and the relatively small nature of
its business, no meaningful points of reference in terms of reputation within
the respective industry was possible. |
|
|
NEGA-SCAN - ADVERSE DATA
MONITORING |
|
|
|
|
CAPITAL (Currency: VND -
Vietnam Dong) |
|||
|
|
SHAREHOLDERS |
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
DOMESTIC SALES &
PURCHASES |
|||||||
|
|||||||
|
|
|||||||
|
|
PAYMENT TERMS |
||||||||||
|
Selling |
||||||||||
|
||||||||||
|
|
||||||||||
|
Purchasing |
||||||||||
|
|
FINANCIAL
STATEMENT - DETAILED |
|
Based on the corporate
laws of Vietnam, legal entities which are Private Company with Limited
Liability are not required to make public disclosure of their annual
financials. Therefore no financials are available for this entity. |
|
Today's
Exchange rate |
: |
|
|
Report Details |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Primary Products
|
Products / Materials / Services Description |
Activity |
|
Cosmetics |
Trading |
|
Industrial chemicals |
Trading |
|
Pharmaceutical products |
Trading |
|
Veterinary medicines |
Trading |
|
SIC PRODUCT
CLASSIFICATION & ACTIVITY |
|||||||||||||||||||||
|
|
HARMONIZED PRODUCT
CLASSIFICATION & ACTIVITY |
||||||||||||||||||||||||||||||
|
|
CORE BUSINESS
DESCRIPTION |
|
Core Business |
|
The primary business
focus of C-PHARMACHEM CO LTD is Trading - Finished products. Cosmetics Industrial chemicals Pharmaceutical products Veterinary medicines |
|
Supplementary Business |
|
In addition to the core
business, C-PHARMACHEM CO LTD also is engaged in the following areas of
business: Exporting Exporting - Finished
products Importing Importing - Finished
products |
|
BANK DETAILS |
||||||||||||||||||||||||||||||
|
|
LOCAL BRANCHES &
MANAGEMENT |
|||||||||||||||
|
|||||||||||||||
|
|
INTERNATIONAL TRADE -
Activity & Markets |
|
|
|
|
|
OFFICE & FACILITIES |
|||||||||||||||
|
|
The following
information relates to the Business Entity's office as listed above: |
|||||||||||||||
|
|
|
|
|
|
||||
|
|
PREVIOUS BUSINESS LICENSE/S |
||||
|
|
|
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.59.08 |
|
UK Pound |
1 |
Rs.99.20 |
|
Euro |
1 |
Rs.80.53 |
INFORMATION DETAILS
|
Analysis Done by
: |
SUM |
|
|
|
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.